Company filings profile · CIK 0002093101
Atrium Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Atrium Therapeutics, Inc. (RNA): 17 filings in the last 90 days vs 11 in the prior 90 (filing-velocity rising ↑ · 1.55×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 9, 2026. Source-linked, daily-refreshed.
Material 8-K events — Atrium Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 8, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| May 14, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Feb 27, 2026 | Entry into a Material Agreement; Change in Control; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
Watch Atrium Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 9, 2026 | 8-K/A | Other Events | ↗ |
| Oct 8, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 22, 2026 | 4 | 4 | ↗ |
| Sep 22, 2026 | 4 | 4 | ↗ |
| Sep 22, 2026 | 4 | 4 | ↗ |
| Sep 22, 2026 | 4 | 4 | ↗ |
| Sep 22, 2026 | 4 | 4 | ↗ |
| Sep 22, 2026 | 4 | 4 | ↗ |
| Sep 22, 2026 | 4 | 4 | ↗ |
| Sep 22, 2026 | 4 | 4 | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 13, 2026 | 10-Q | 10-Q | ↗ |
| Aug 13, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 27, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 14, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 14, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 27, 2026 | SCHEDULE 13G | ↗ | |
| Apr 22, 2026 | 4 | 4 | ↗ |
| Apr 22, 2026 | 4 | 4 | ↗ |
| Apr 22, 2026 | 4 | 4 | ↗ |
| Apr 22, 2026 | 4 | 4 | ↗ |
| Apr 22, 2026 | 4 | 4 | ↗ |
| Apr 22, 2026 | 4 | 4 | ↗ |
| Apr 17, 2026 | S-8 | S-8 | ↗ |
| Apr 8, 2026 | SCHEDULE 13G | ↗ | |
| Mar 2, 2026 | 4 | 4 | ↗ |
| Mar 2, 2026 | 4 | 4 | ↗ |
| Mar 2, 2026 | 4 | 4 | ↗ |
| Mar 2, 2026 | 4 | 4 | ↗ |
| Mar 2, 2026 | 4 | 4 | ↗ |
| Feb 27, 2026 | 8-K | Entry into a Material Agreement; Change in Control; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Feb 26, 2026 | 3 | 3 | ↗ |
| Feb 26, 2026 | 3 | 3 | ↗ |
| Feb 26, 2026 | 3 | 3 | ↗ |
| Feb 26, 2026 | 3 | 3 | ↗ |
| Feb 26, 2026 | 3 | 3 | ↗ |